Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of October 2018. The report serves to notify shareholders of the upcoming Annual General Meeting of Shareholders scheduled for December 3, 2018, at the company's offices in Petach Tikva, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding shareholder meetings and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing. The document focuses solely on corporate governance procedures.
Guidance, Outlook, and Corporate Actions
The company announced the following corporate actions and details regarding the Annual General Meeting:
- Meeting Date and Time: December 3, 2018, at 12:00 p.m. (Israel time).
- Location: Company offices in Petach Tikva, Israel.
- Documents Furnished:
- Notice and Proxy Statement (Exhibit 99.1) detailing proposals and voting procedures.
- Proxy Card for ordinary share holders (Exhibit 99.2).
- Voting Instruction Card for American Depositary Share holders (Exhibit 99.3).
The filing text does not provide specific guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Key Facts for Investors to Verify
- Verify the specific proposals to be voted upon in the attached Notice and Proxy Statement (Exhibit 99.1).
- Confirm the deadline for submitting proxy cards or voting instruction cards to ensure participation in the December 3, 2018 meeting.
- Review the company's most recent Form 20-F or quarterly reports for actual financial performance data, as this filing contains none.